Baylor Genetics’ Post

The American College of Medical Genetics and Genomics (ACMG) recommends Whole Genome Sequencing (WGS) and Whole Exome Sequencing (WES) as first-tier tests for patients with congenital anomalies (CA), developmental delay (DD), and intellectual disabilities (ID).  Our WGS/WES can help with the identification of an underlying diagnosis for patients with CA/DD/ID, informing treatment and shortening the diagnostic odyssey.  Learn more: https://bit.ly/4bWsOCt #ThinkBG #BGreat #ACMG 

We’re committed to finding answers for you and your patients. Our Whole Genome/Exome Sequencing (WGS/WES), now with RNAseq, will give you the greatest chance for a prompt diagnosis, ending the diagnostic journey and enabling personalized care. Our WES/WGS tests provide: -Results in 3 weeks for standard testing, starting at 5 days for rapid -Recommended as a first-tier test by ACMG, AES, AANEM, NSGC -Flexible test ordering & reporting, in-house experts, dedicated customer service and billing teams -Extensive insurance coverage, including Cigna & UnitedHealthcare -RNASeq offered as a reflex for WGS/WES after identifying a qualified variant, providing quicker and actionable diagnostic answers Learn more about WGS/WES and our comprehensive test menu: https://bit.ly/4bWsOCt #ThinkBG #BGreat #GenomeSequencing #ExomeSequencing

Did you know? Baylor Genetics is the sole sequencing core partner for the National Institutes of Health’s Undiagnosed Diseases Network (UDN), which brings together clinical and research experts to solve the most challenging medical cases.

It’s Day 3 at #MitoMed24! Come chat with our team and learn how our mitochondrial testing and genome sequencing are transforming patient care and contributing to better health outcomes. https://bit.ly/umdf24 #ThinkBG #BGreat

Are you passionate about healthcare excellence? We're seeking Quality Assurance (QA) Specialists to enhance our analytical processes consistent with our values and mission; with openings in three key areas for QA Specialists. In this role, you'll maintain robust quality systems and play a pivotal role in review of validation protocols. Learn more: https://bit.ly/45xkJBu #ThinkBG #BGreat #NowHiring

Thank you to everyone who stopped by our poster presentation last night on Low-Level Large Deletions in Mitochondria Genomes: A Potential Diagnosis of Mitochondrial Diseases. To learn more about Baylor Genetics at #MitoMed24, click here: https://lnkd.in/gHCKDQdG

We can't wait to connect with you at #MitoMed24 in Cleveland to share what Baylor Genetics has been up to. It's an exciting opportunity for us to engage with patients and their families within the mito community, providing support as they navigate challenging medical conditions. Come chat with our team, learn about our latest updates on how our mitochondrial testing and genome sequencing are transforming patient care and contributing to better health outcomes. Learn more: https://bit.ly/umdf24 #ThinkBG #BGreat #MitoMed #UMDF

Sickle Cell Disease (SCD) is an inherited blood disorder that forms sickle/crescent-shaped red blood cells, blocking blood flow/oxygen to parts of the body.